[HTML][HTML] Ketamine versus ECT for nonpsychotic treatment-resistant major depression

A Anand, SJ Mathew, G Sanacora… - … England Journal of …, 2023 - Mass Medical Soc
Background Electroconvulsive therapy (ECT) and subanesthetic intravenous ketamine are
both currently used for treatment-resistant major depression, but the comparative …

Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.

A Anand, SJ Mathew, G Sanacora… - The New England …, 2023 - europepmc.org
Background Electroconvulsive therapy (ECT) and subanesthetic intravenous ketamine are
both currently used for treatment-resistant major depression, but the comparative …

[PDF][PDF] Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression

A Anand, SJ Mathew, G Sanacora, JW Murrough… - N Engl J …, 2023 - thriveketamine.com
The new england journal of medicine Page 1 The new england journal of medicine n engl j med
388;25 nejm.org June 22, 2023 2315 established in 1812 June 22, 2023 vol. 388 no. 25 The …

Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression

A Anand, SJ Mathew, G Sanacora… - The New England …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Electroconvulsive therapy (ECT) and subanesthetic intravenous ketamine are
both currently used for treatment-resistant major depression, but the comparative …

Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression

A Anand, SJ Mathew… - New England …, 2023 - utsouthwestern.elsevierpure.com
BACKGROUND Electroconvulsive therapy (ECT) and subanesthetic intravenous ketamine
are both currently used for treatment-resistant major depression, but the comparative …

Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression

A Anand, SJ Mathew, G Sanacora… - … England Journal of …, 2023 - pure.johnshopkins.edu
BACKGROUND Electroconvulsive therapy (ECT) and subanesthetic intravenous ketamine
are both currently used for treatment-resistant major depression, but the comparative …